Latest Insider Transactions at Revance Therapeutics, Inc. (RVNC)
This section provides a real-time view of insider transactions for Revance Therapeutics, Inc. (RVNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revance Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revance Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,607
-4.0%
|
$39,105
$15.79 P/Share
|
|
Mar 15
2022
|
Aubrey Rankin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,372
-1.44%
|
$20,580
$15.79 P/Share
|
|
Mar 15
2022
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
5,110
-5.49%
|
$76,650
$15.79 P/Share
|
|
Mar 15
2022
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,304
-0.43%
|
$49,560
$15.79 P/Share
|
|
Mar 15
2022
|
Abhay Joshi COO, President of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,607
-2.11%
|
$39,105
$15.79 P/Share
|
|
Feb 15
2022
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,924
-2.17%
|
$38,012
$13.35 P/Share
|
|
Feb 15
2022
|
Abhay Joshi COO, President of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-1.99%
|
$65,689
$13.35 P/Share
|
|
Feb 15
2022
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,429
-1.2%
|
$31,577
$13.35 P/Share
|
|
Feb 02
2022
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
42,349
+31.86%
|
-
|
|
Feb 02
2022
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
52,395
+23.21%
|
-
|
|
Feb 02
2022
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
175,649
+15.02%
|
-
|
|
Feb 02
2022
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
42,349
+28.66%
|
-
|
|
Dec 31
2021
|
Tobin Schilke CFO |
BUY
Other acquisition or disposition
|
Direct |
404
+0.59%
|
$5,252
$13.87 P/Share
|
|
Dec 15
2021
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
513
-0.5%
|
$7,695
$15.92 P/Share
|
|
Dec 15
2021
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-2.25%
|
$23,340
$15.92 P/Share
|
|
Dec 13
2021
|
Angus C. Russell Director |
BUY
Open market or private purchase
|
Direct |
6,400
+19.21%
|
$96,000
$15.74 P/Share
|
|
Dec 03
2021
|
Aubrey Rankin Director |
BUY
Open market or private purchase
|
Direct |
30,000
+23.91%
|
$420,000
$14.43 P/Share
|
|
Nov 29
2021
|
Mark J Foley CEO |
BUY
Open market or private purchase
|
Indirect |
40,000
+26.51%
|
$480,000
$12.9 P/Share
|
|
Nov 09
2021
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
35,920
+26.06%
|
-
|
|
Oct 13
2021
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
42,096
-5.19%
|
$968,208
$23.08 P/Share
|
|
Sep 27
2021
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
1,675
-3.39%
|
$50,250
$30.0 P/Share
|
|
Aug 16
2021
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Direct |
9,364
-12.51%
|
$243,464
$26.34 P/Share
|
|
Aug 15
2021
|
Aubrey Rankin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,949
-6.2%
|
$128,674
$26.02 P/Share
|
|
Jul 28
2021
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
54,332
-10.56%
|
$1,629,960
$30.08 P/Share
|
|
Jul 26
2021
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
55,382
-13.46%
|
$1,606,078
$29.72 P/Share
|
|
Jun 30
2021
|
Mark J Foley CEO |
BUY
Other acquisition or disposition
|
Direct |
882
+0.11%
|
$21,168
$24.09 P/Share
|
|
Jun 30
2021
|
Tobin Schilke CFO |
BUY
Other acquisition or disposition
|
Direct |
446
+0.64%
|
$10,704
$24.09 P/Share
|
|
Jun 30
2021
|
Dustin S Sjuts President |
BUY
Other acquisition or disposition
|
Direct |
882
+1.32%
|
$21,168
$24.09 P/Share
|
|
May 05
2021
|
Jill Beraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+17.43%
|
-
|
|
May 05
2021
|
Julian S Gangolli Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+16.36%
|
-
|
|
May 05
2021
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
674
+8.82%
|
-
|
|
May 05
2021
|
Chris Nolet Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+17.43%
|
-
|
|
May 05
2021
|
Angus C. Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+16.36%
|
-
|
|
May 05
2021
|
Philip J. Vickers Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+14.5%
|
-
|
|
May 05
2021
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
674
+8.69%
|
-
|
|
Apr 15
2021
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
411
-0.63%
|
$11,508
$28.16 P/Share
|
|
Apr 05
2021
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
2
-0.0%
|
$56
$28.28 P/Share
|
|
Mar 15
2021
|
Abhay Joshi COO, President of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,354
-1.04%
|
$36,558
$27.73 P/Share
|
|
Mar 15
2021
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
2,881
-5.5%
|
$77,787
$27.73 P/Share
|
|
Mar 08
2021
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,408
+50.0%
|
-
|
|
Mar 04
2021
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
33,119
-7.45%
|
$827,975
$25.43 P/Share
|
|
Mar 01
2021
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,294
+50.0%
|
-
|
|
Feb 15
2021
|
Abhay Joshi COO, President of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
4,848
-1.82%
|
$135,744
$28.97 P/Share
|
|
Feb 15
2021
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,410
-1.78%
|
$67,480
$28.97 P/Share
|
|
Feb 15
2021
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,657
-1.87%
|
$74,396
$28.97 P/Share
|
|
Feb 02
2021
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,715
+4.78%
|
-
|
|
Feb 02
2021
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
19,346
+26.98%
|
-
|
|
Feb 02
2021
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+24.05%
|
-
|
|
Feb 02
2021
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+24.98%
|
-
|
|
Feb 02
2021
|
Abhay Joshi COO, President of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+14.39%
|
-
|